# Insulin Therapy for Postreperfusion Hyperglycemia

> **NCT03152890** · PHASE4 · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Hyperglycaemia (Diabetic)
- Liver Transplantation

## Interventions

- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT03152890
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-05-15
- **Primary completion:** 2024-12-15
- **Final completion:** 2024-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03152890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03152890, "Insulin Therapy for Postreperfusion Hyperglycemia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03152890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*